Advertisement
U.S. markets closed

Streamline Health Solutions, Inc. (STRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4800+0.0142 (+3.05%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.4658
Open0.4650
Bid0.4500 x 4000
Ask0.5099 x 2200
Day's Range0.4650 - 0.5000
52 Week Range0.2100 - 1.9000
Volume23,034
Avg. Volume99,983
Market Cap28.364M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-0.3500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for STRM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Streamline Health Solutions, In
    The Argus Mid-Cap Model PortfolioSmall- and mid-cap stocks (SMID) have underperformed large-caps over the past 12 months, but may be in a better position to generate market-beating returns going forward. SMID companies tend to focus on domestic markets, so their businesses could be less disrupted by the fallout from global events. As well, the prices of SMID stocks generally are lower than the prices of large-caps. As well, there are long stretches in the record books when SMID stocks have outperformed large-caps. That said, SMID stocks can be risky. The standard deviation for monthly returns was 5.7% for SMID stocks over a 2003-2021 test period, versus 4.3% for large-caps. Still, despite the risks, diversified investors look to have exposure to small- and mid-caps based on the long-term performance record.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Insider Monkey

    20 Most Valuable Digital Health Companies In The US

    In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]

  • GlobeNewswire

    Streamline Health® Improves Liquidity Position and Appoints New Directors

    Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior lo

  • GlobeNewswire

    Streamline Health® Expands Agreement With Existing eValuator™ Client to Add RevID™

    6 facility New York health system becomes first client leveraging both eValuator and RevID to improve revenue integrity pre-bill Atlanta, GA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded an existing contract with a 6 facility, Oracle Cerner-EHR based health system. The system has been using eValuator for pre-bill code auditing fo